Navigation Links
Noscira Presents Results of Phase IIa Clinical Trial with Nypta(R) (Tideglusib) on Alzheimer's Disease at International Conference on Alzheimer's Disease (ICAD)
Date:7/15/2010

- Treatment with Nypta(R) (Tideglusib) (NP-12) was tolerated and produced positive effects on Alzheimer's patients in four of the five efficacy variables examined in the trial.

- In view of the promising results of this trial, Noscira is preparing the next Phase IIb trial on Alzheimer's patients in order to progress with the clinical development of this novel compound.

MADRID, July 15 /PRNewswire/ -- Noscira, the Grupo Zeltia (ZEL.MC) subsidiary specialized in researching and developing drugs for treating neurodegenerative diseases, presented the results of a Phase IIa clinical trial of Nypta(R) (Tideglusib) on Alzheimer's disease (AD) at the International Conference on Alzheimer's Disease (ICAD), held in Honolulu (Hawaii) from July 10-15, 2010.

Dr. Teodoro del Ser, Director of Clinical Development at Noscira, gave an oral session in the "Therapeutic Strategies" symposium in which he reported that treatment with Nypta(R) (Tideglusib) for 20 weeks was tolerated and had a positive impact on patients' cognitive performance. In order for these results to be statistically significant, they must be confirmed in a Phase IIb trial in which a larger group of patients will be treated for one year.

The Phase IIa trial, which was conducted at three centers in Germany based on advice from experts at the European Medicines Agency (EMA), is the first clinical trial of Nypta(R) (Tideglusib) on a group of Alzheimer's patients. The trial was designed with the primary goal of assessing the safety and tolerability of Nypta(R) (Tideglusib) on these patients.

The
'/>"/>

SOURCE Group Zeltia
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
3. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
4. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
5. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
6. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
7. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
8. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
9. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
10. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
11. Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... June 2, 2015 Nevro Corp. (NYSE: ... providing innovative evidence-based solutions for the treatment of chronic ... public offering of its common stock at a public ... The offering consists of 1,764,705 shares to be sold ... certain of its stockholders, resulting in aggregate proceeds of ...
(Date:6/2/2015)... Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), a biopharmaceutical ... for the treatment of central nervous system disorders, today ... President and CEO, will deliver a corporate presentation at ... York City on Thursday, June 4, 2015 ... at the Jefferies Global Healthcare Conference will be available ...
(Date:6/2/2015)... , June 2, 2015  Endo International plc (NASDAQ: ... announced today that it has commenced an underwritten public ... All ordinary shares in the offering are to be ... also grant to the underwriters of the Offering an ... the date of the final prospectus supplement, to purchase ...
Breaking Medicine Technology:Nevro Announces Pricing of Upsized Public Offering of Common Stock 2Nevro Announces Pricing of Upsized Public Offering of Common Stock 3Endo International plc Announces Proposed Public Offering of $1.75 Billion of Ordinary Shares 2Endo International plc Announces Proposed Public Offering of $1.75 Billion of Ordinary Shares 3Endo International plc Announces Proposed Public Offering of $1.75 Billion of Ordinary Shares 4
... 23, 2011 A recently enacted standard has replaced ...  This superseding standard, the Statement on Standards for Attestation ... 15, 2011 and pushes service organizations to enforce a ... (Logo: http://photos.prnewswire.com/prnh/20080206/AQW030LOGO-b ) Rising ...
... 23, 2011 Unilife Corporation ("Unilife" or "Company") (NASDAQ: ... presenting at the Jefferies 2011 Global Healthcare Conference in ... Officer of Unilife, is scheduled to present at 5:00 ... Wednesday, September 28, 2011. The conference presentation ...
Cached Medicine Technology:Rising Medical Solutions, an Early Adopter of SAS 70's Replacement Standard 2Rising Medical Solutions, an Early Adopter of SAS 70's Replacement Standard 3Unilife to Present at the Jefferies 2011 Global Healthcare Conference in London 2
(Date:6/2/2015)... (PRWEB) June 02, 2015 Allred Dental, a ... coupon for the months June-September, 2015 along with a $100 ... for limited time only. , “Sometimes wisdom teeth can be ... or jawbone. They can also only partially break through the ... and recovery is easier in young people, as they do ...
(Date:6/2/2015)... June 02, 2015 The organic cotton ... Market Report, an annual study conducted by Textile Exchange, ... textile industry. The report, released today, encompasses extensive data ... a worldwide level and also takes the opportunity to ... market. , The last several years have ...
(Date:6/2/2015)... 2015 The JK-A0100EU secure smart card ... government, finance and healthcare. However, this keyboard can also ... control to enhance the security of their network. , ... authentication of a Smart Card before allowing access to ... card reader, the keyboard supports secure PIN entry. , ...
(Date:6/2/2015)... Kan. (PRWEB) June 02, 2015 Concorde ... Bell as President and COO. Bell will manage day-to-day ... , “I’m looking forward to the opportunity to help ... students,” Bell said. “I joined Concorde in part due ... Institute that highlighted Concorde colleges in Memphis and Portland.” ...
(Date:6/2/2015)... Angeles, CA (PRWEB) June 02, 2015 ... Factory" system was released to public yesterday, and ... the Internet. HonestyFirstReviews.com's senior product reviewer Tiffany Hendricks ... a detailed review of the course on her ... training courses available for Internet marketers looking to ...
Breaking Medicine News(10 mins):Health News:$100 Off Coupon for Wisdom Teeth Extractions Offered at Allred Dental 2Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 2Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 3Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 4Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 5Health News:Introducing the New CHERRY JK-A0100EU Keyboard with Integrated Smart Card Reader for Access Control Security 2Health News:Concorde Career Colleges Announces New President and COO 2Health News:100K Factory - Review of Aidan Booth and Steve Clayton's New IM System Published 2
... The Swanson ... with unique benefits. , ... ND (Vocus) May 19, 2010 -- Friendly bacteria may seem like an oxymoron—we have been ... everyone needs bacteria to survive. Bacteria are responsible for the digestion of food, for ...
... ... a new Class IV Laser along with properly applied Manual Physical Therapy have been producing ... ... PT, MCMT world renowned experts in the area of Myofascial Pain examine and treat chronic ...
... An emerging population of middle-aged cystic fibrosis patients contains ... patients who lived for decades without a diagnosis or ... National Jewish Health. The comprehensive analysis of this over-40 ... Journal of Respiratory and Critical Care , may help ...
... disorders are still being prescribed for extended periods to British ... despite warnings against long-term use, according to a University of ... Health Policy , the study by researchers at UBC,s Centre ... of its kind to examine the use of benzodiazepines such ...
... differ, researchers find , WEDNESDAY, May 19 (HealthDay News) ... appear to be equally effective, a new study reveals, ... Known as mid-urethral slings, the techniques are often used ... from activities such as coughing, sneezing or laughing. , ...
... sleeping toddlers show differences in response to bedtime stories ... that a simple brain scan performed in infants and ... early detection and early intervention. , The test ... spoken words in sleeping children. , "We,re focusing ...
Cached Medicine News:Health News:FemFlora Reformulated with New Complex of Probiotic Bacteria 2Health News:New Laser Technology Combined with Manual Physical Therapy Offer Pain Relief to Chronic Pain Sufferers 2Health News:Older patients offer insight into the future of cystic fibrosis 2Health News:Older patients offer insight into the future of cystic fibrosis 3Health News:Long-term use of anti-anxiety drugs continues in B.C. despite known health risks: UBC study 2Health News:Female Incontinence Surgeries Look Equally Effective 2Health News:New Hope for Early Detection of Autism 2Health News:New Hope for Early Detection of Autism 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: